Saturday, November 23, 2024
Home Tags Ctxr

Tag: ctxr

2024 Watch List

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Editor / Curator -
2023 Watch List

Citius Pharma (CTXR). Reports Fiscal First Quarter 2023 Financial Results and...

Editor / Curator -
2021 Watch List

Report on Citius Pharma (CTXR): North Shore Research Issues a $10...

Editor / Curator -
2021 Watch List

Citius Pharmaceuticals Reports Topline Data from the Pivotal Phase 3 Study...

Editor / Curator -
@NCI
CoronaVirus

Citius (CTXR) Expands Scientific Advisory Board. Dr. John Laffey, Expert in...

Editor / Curator -
Issam Radd
2021 Watch List

Citius (CTXR): Halt For Superiority On The Horizon? (SeekingAlpha).

Editor / Curator -
Biotech Stock Review. Citius, CTXR
Incubator

More Great News From Citius Pharma (CTXR).

Editor / Curator -
Internet Stock Review
2021 Watch List

Stocks On The Move!

Editor / Curator -
CoronaVirus

Citius Pharma (CTXR) Updates Shareholders.

Editor / Curator -
Tiki Hut Fund

Seven of the World’s Top Performing Stocks, Every Morning.

Editor / Curator -
1234Page 1 of 4

Latest article

Nine Page Summary Report on GeoVax (GOVX)

2024 Watch List Editor / Curator -
This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

2024 Watch List Editor / Curator -
Award of BARDA Project NextGen contract represents a significant milestone event; Total value...

Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

All News Editor / Curator -
Can You Imagine Selling Solgenix at $2.00 yesterday. And to be honest, news wasn't all that big - such...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.